Avalon GloboCare Corp. 8-K

What Happened Avalon GloboCare Corp. (ALBT) announced on Feb. 26, 2026 (closing Feb. 27, 2026) a private placement of securities to institutional investors. The deal included 490,197 common shares at $0.51 each, pre-funded warrants exercisable into up to 5,882,353 common shares (at $0.5099 each), Series A-1 warrants to buy up to 6,372,550 shares and Series A-2 warrants to buy up to 6,372,550 shares (each common warrant has a $0.51 exercise price). Prefunded warrants are immediately exercisable at $0.0001 per share. The company expects net proceeds of approximately $2.8 million to use for operating expenses and working capital.

Key Details

• Purchase agreements dated Feb. 26, 2026; private placement closed Feb. 27, 2026.
• Securities sold: 490,197 common shares; prefunded warrants for 5,882,353 shares; Series A-1 and A-2 warrants for 6,372,550 shares each; placement agent warrants for 318,628 shares. Total potential shares issuable if all exercised: up to ~19.44 million.
• Warrant terms: common warrants exercise price $0.51; Series A-1 expire 5 years after stockholder approval, Series A-2 expire 18 months after stockholder approval; common warrants not exercisable until stockholder approval is obtained. Prefunded warrants exercisable immediately at $0.0001.
• Ownership caps: purchasers may not exercise to own >4.99% of outstanding common stock post-exercise (can elect up to 9.99% with 61 days’ prior notice).
• Fees and placement agent compensation: H.C. Wainwright received 7.0% cash fee + 1.0% management fee and placement agent warrants (318,628 shares, $0.6375 exercise); Roth Capital paid $75,000 as financial advisor.
• Registration rights: company must file a resale registration for the sold shares and underlying shares within 45 days and use best efforts to have it effective within 75 days (90 days if SEC conducts a full review).

Why It Matters This financing provides Avalon GloboCare with immediate cash for operations (net ≈ $2.8M) but creates meaningful potential dilution if the prefunded warrants and common warrants are exercised (up to ~19.44M additional shares). Most common warrants cannot be exercised until shareholders approve their issuance and the shares underlying them, so timing and shareholder votes will affect when dilution may occur. Retail investors should watch for the registration filing and any upcoming stockholder vote, as well as future updates on use of proceeds and potential share-count changes.